Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

RECRUITING
A Study of Sovilnesib in Subjects with Ovarian Cancer
Description

This is a randomized, phase 1b study to assess the safety, tolerability, pharmacokinetics (PK), and efficacy of sovilnesib at different dose levels to establish the Recommended Phase 2 Dose (RP2D) of sovilnesib in subjects with high grade serous ovarian cancer (HGSOC).